News Innovation

Biotech advocates call on the feds to strengthen industry incentives

Advocates press for support from Ottawa to help the domestic biotech industry grow.

Elaine Campbell, left, interim president of Innovative Medicines Canada, says the long-serving Scientific Research and Experimental Development tax credit offers such negligible benefits for certain pharmaceutical companies they don't even bothering reporting in Canada to ascertain it. However, Andrew Casey, president of BIOTECanada, called it 'hugely important' for the biotechnology industry. Photographs courtesy of Innovative Medicines Canada and BIOTECanada

By MARCO VIGLIOTTI

PUBLISHED : Wednesday, Sept. 7, 2016 12:00 AM

If you are already a subscriber


Subscribe to The Hill Times

Subscribe to the print and electronic editions and get instant access to The Hill Times online.


Quick Purchase

Purchase this week's edition of The Hill Times in electronic format (PDF) for $5.00.


Quick Purchase

Purchase Story Issue in electronic format (PDF) for $5.00.


  
  



More Stories In This Section

1

PBO again at odds with feds over budget details

2

People are better haters than forgivers

3

Spouses of Canadians to get permanent residency immediately: McCallum

4

‘Very, very few’ Syrian refugees came to Canada from refugee camps: CBSA official Bolduc

5

Labour Minister claims Conservatives buried ‘significant’ union report in last Parliament, releases it